Castle Biosciences, Inc. ( CSTL) - Stock Earnings
CSTL Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -2.3 million USD | 87.0 million USD |
| 2026Q1 | -14.5 million USD | 83.7 million USD |
| 2026Q2 | -2.1 million USD | 103.5 million USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
CSTL Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -57.5 million USD | 219.8 million USD |
| 2024 | 18.2 million USD | 332.1 million USD |
| 2025 | -24.2 million USD | 344.2 million USD |
| 2026 Est. | — | — |
CSTL
Price: $32.91
52 week price:
Earnings Per Share: -0.64 USD
Exchange: NGM
Sector: Healthcare
Industry: Diagnostics & Research
Country: United States
Volume: 126500
Market Capitalization: 952.5 million